Controversies & Ethical Concerns

The autistic self-advocacy and neurodiversity movements have mounted sustained criticism of ABA as fundamentally coercive, arguing it prioritizes behavioral compliance and social conformity over autistic wellbeing. Autistic adults who underwent childhood ABA have reported lasting psychological harm including anxiety, PTSD symptoms, and identity confusion from being trained to suppress natural behaviors (stimming, atypical eye contact, echolalia).

ABA’s founder Ole Ivar Lovaas used electric shocks, slapping, and food deprivation as aversive techniques in early autism treatment at UCLA. The Judge Rotenberg Center continued using electric skin shock devices (GED) on students with disabilities through 2020, when the FDA banned the practice. A federal court later vacated the ban in 2021.

Meta-analytic evidence for ABA’s effectiveness is characterized as limited by methodological concerns: lack of blinding, reliance on single-subject designs, outcomes measured primarily on behavioral compliance rather than subjective wellbeing or autistic quality of life, and potential conflicts of interest given the $17+ billion ABA services industry.

Carl Jung entered into an intimate relationship with Sabina Spielrein, who became his patient at the Burghölzli clinic in 1904, when she was 19 and he was her treating psychiatrist. Historians dispute both how far the relationship went (some read the surviving Jung-Spielrein correspondence as evidence of a consummated sexual affair, others as an intense but unconsummated romantic and erotic attachment) and when it began: Spielrein left active treatment around 1905, and the relationship's best-documented intimate phase dates to several years afterward, by which point she had become Jung's research assistant and a medical student rather than his patient. The relationship was concealed for decades. Spielrein later became a psychoanalyst herself. Whatever its exact form, the entanglement is a documented boundary-relevant episode involving one of the most influential figures in depth psychology, unfolding during the period when he was developing core concepts of analytical psychology.

Jung assumed the presidency of the International General Medical Society for Psychotherapy in 1933 after its German section was reorganized under Nazi leadership. He oversaw the Society during the period when Jewish analysts were expelled from the German section. Jung published editorials distinguishing between 'Jewish' and 'Aryan' psychology, writing that 'the Aryan unconscious has a higher potential than the Jewish' (Zentralblatt, 1934). The extent to which these actions reflected antisemitic conviction versus political opportunism versus an attempt to preserve international psychotherapy remains debated.

McKay and Coreil (2024) published a formal analysis in Medical Hypotheses concluding that Brainspotting meets established criteria for pseudoscience: model loopholes preventing falsification, emphasis on confirmation over disconfirmation, overreliance on anecdotal evidence and case reports, excessive ‘science-ism’ (claiming dramatic brain connectivity where none plausibly exists), and built-in insulation from disconfirmation. The authors found no evidence that the proposed neural circuitry is involved in posttraumatic stress or traumatic memories.

Steven Novella at Science-Based Medicine characterized Brainspotting as ‘classic pseudoscience,’ noting that the claimed midbrain maps to specific eye positions and subsequently to traumatic memories have no neuroanatomical basis, and that Grand has had 23 years to produce rigorous evidence but has focused on building a treatment brand rather than testing underlying principles.

Lilienfeld et al. (2015) included Brainspotting among questionable and controversial treatments for trauma in the Canadian Journal of Psychiatry, noting claims based on ‘scientifically dubious assumptions’ about aversive experiences being banished from consciousness.

Context: EMDR faced nearly identical criticisms in its first two decades (implausible mechanism, origin in a single anecdotal observation, founder-led research, and accusations of pseudoscience) before accumulating enough independent RCTs to earn guideline status. Whether Brainspotting follows the same trajectory or remains unsupported is an open question. As of 2025, BSP has one independent RCT (Horton et al., 2023) and several pilot studies, while EMDR had a comparable evidence base at a similar point in its development.

Jauhar et al. (2014) published a meta-analysis in the British Journal of Psychiatry finding only small effect sizes for CBTp on positive symptoms (d=0.25) and negative symptoms (d=0.13), with effects shrinking further when controlling for blinding bias. The paper triggered a sustained debate about whether CBTp’s benefits for core psychotic symptoms had been overstated in clinical guidelines.

McKenna and Kingdon (2014) argued in BMJ that CBTp had been ‘oversold’ as a treatment for schizophrenia. Laws et al. (2018) extended the critique, finding no significant benefit for quality of life and non-significant effects on functioning at follow-up. The debate highlighted how NICE continued to recommend CBTp despite effect sizes comparable to treatments considered insufficiently supported for other conditions.

The U.S. Food and Drug Administration obtained a federal injunction against Reich’s orgone accumulators, ordering them destroyed along with publications making therapeutic claims. Reich refused to comply, was found in contempt of court, and was sentenced to two years in federal prison. He died in Lewisburg Federal Penitentiary in November 1957. FDA agents supervised the destruction of orgone accumulators and burning of his publications: one of the most notable instances of government-ordered book burning in U.S. history.

Despite being one of the most strongly evidence-supported treatments for substance use disorders, contingency management has been resisted by treatment systems due to moral objections to 'paying patients to stay sober.' State Medicaid programs have historically refused to cover incentive-based interventions, and many treatment programs reject the approach on philosophical grounds: that recovery should be intrinsically motivated, not externally rewarded. This has created a gap between research evidence and clinical implementation that is wider for contingency management than for almost any other evidence-based treatment.

The evidence base rests on one randomized controlled trial (n = 54), published as an interim analysis of an ongoing study, using a waitlist rather than an active comparator. Waitlist designs reliably inflate effect sizes relative to active-control designs because they cannot account for attention, expectancy, therapeutic alliance, or spontaneous remission. The groups also differed significantly at baseline on the arousal and reactivity subscale (p = .036, d = 0.589) in the direction favouring DBR. The developer (Corrigan) and the laboratory that generated the supporting neuroimaging (Lanius) are both represented on the author list, a structure common to practitioner-developed modalities and a recognized source of allegiance effects.

The core mechanism (that an orienting sequence mediated by the superior colliculus, locus coeruleus, and periaqueductal grey encodes a distinct "pre-affective shock" accessible in session) was published in Medical Hypotheses, a journal explicitly devoted to untested theoretical proposals. The underlying brainstem circuitry is well characterized in animal models, but the clinical inference (that this sequence is retrievable and modifiable through attention to head and neck tension) is an extrapolation, not a demonstrated finding.

DBR is presented as a registered mark of a private company (Deepbrainreorienting Ltd, Glasgow), with sequential paid training levels and proprietary DBR-P (practitioner), DBR-C (consultant), and DBR-T (trainer) approval described as the only certification endorsed by the developer. Approval is voluntary and not required in order to practise DBR, but it carries its own application fee on top of training costs. The structure mirrors the modality-empire pattern seen across EMDR, Brainspotting, Somatic Experiencing, and IFS: revenue from training and credentialing creates an incentive against findings that would narrow the approach's indications.

The core theoretical claim of EFT, that tapping on acupressure meridian points corrects disruptions in the body's energy system, has no established physiological basis. Controlled studies (Waite & Holder, 2003) found that tapping on non-meridian points or even on a doll produced similar results, suggesting the tapping locations are irrelevant and the mechanism is likely non-specific (distraction, exposure, therapeutic alliance). Bakker (2013) characterized energy psychology as making extraordinary claims with less than ordinary evidence.

EFT certification is open to unlicensed practitioners with no clinical training requirement, raising concerns about untrained individuals treating serious clinical conditions. Gaudiano et al. (2012) found that therapists using energy techniques were more likely to hold unfavorable views toward evidence-based practice. EFT is not listed as an empirically supported treatment by APA Division 12.

Multiple energy psychology modalities, including EFT and Advanced Integrative Therapy (AIT), make claims about treating or preventing cancer through energy-based interventions. AIT's website maintains a dedicated cancer treatment section. These claims lack any controlled evidence, risk delaying evidence-based oncological treatment, and represent a potential harm to vulnerable populations seeking cancer care.

Shapiro’s account of EMDR’s origin (that she noticed eye movements reduced distress during a walk) has been questioned by researchers who noted that saccadic eye movements are physiologically imperceptible. Others have suggested EMDR’s actual origins may lie in NLP training. The 2008 IOM report found insufficient evidence and criticized studies for methodological flaws including allegiance bias.

Critics noted Shapiro repeatedly increased EMDR training length and expense, allegedly in response to trials casting doubt on eye movement efficacy. EMDRIA requirements have been characterized by some academics as restricting scientific exploration.

Flash Technique was introduced in 2017 and has an emerging but limited evidence base: pilot and case-series studies only, including Manfield et al.'s (2017) four-case series, with no completed RCT: the multisite ENHANCE RCT is still in progress. The proposed mechanism (brief, interrupted exposure combined with positive engagement to reduce traumatic memory disturbance without significant distress) has not been empirically validated. The technique has gained rapid adoption among trauma therapists despite the evidence base being in early development.

Fritz Perls engaged in sexual relationships with patients and trainees throughout his career, particularly during his years at Esalen Institute (1964–1969). These are documented in multiple biographical accounts. Perls's therapeutic style involved public confrontation and deliberate provocation: 'hot seat' demonstrations where individuals were challenged before audiences. Participants reported feeling humiliated and emotionally exposed. Perls openly combined therapeutic authority with sexual pursuit, treating the boundary between therapist and lover as a bourgeois constraint to be transcended.

The 'Dionysian' lineage of Gestalt therapy (emphasizing catharsis, confrontation, and emotional intensity) has been linked to reports of psychological harm and abusive training environments. This approach prioritizes breaking through defenses over establishing safety, and some training institutes in this lineage have faced allegations of coercive group dynamics, boundary violations between trainers and trainees, and an institutional culture that frames objections to aggressive technique as 'resistance.'

Gottman’s widely cited claim of predicting divorce with “94% accuracy” has been challenged by statisticians and researchers who note that the figure derives from post-hoc classification (fitting a model to data already collected) rather than true prospective prediction. When tested prospectively, prediction accuracy drops substantially. Critics argue the distinction between ‘prediction’ and ‘postdiction’ has been blurred in popular presentations of the research, creating an inflated public perception of the method’s empirical precision.

Former patient filed suit against Françoise Bourzat (Hakomi-certified therapist) alleging she engaged in an inappropriate sexual relationship during therapy.

The Hakomi Institute unconditionally revoked Bourzat’s certificate for ‘multiple ethical violations’: the only such revocation in institute history. The institute’s past director confirmed the unprecedented severity. Bourzat continued practicing as an unlicensed psychedelic guide.

Will Hall published detailed allegations of sexual boundary violations by Bourzat’s partner Aharon Grossbard during psychedelic sessions in the 1990s. Additional former clients and students corroborated. Grossbard’s protégé Eyal Goren subsequently surrendered his California license facing abuse allegations. Hakomi Institute acknowledged Hall’s ‘courage’ but found no ethical violations by teacher Manuela Mischke-Reeds.

Hall published evidence suggesting systematic insurance fraud: sessions allegedly billed under Grossbard’s LMFT license when unlicensed Bourzat was the actual provider.

Steven Novella (Yale neurologist, Science-Based Medicine) analyzed HeartMath as energy-medicine pseudoscience. He called 'coherence' fake jargon, argued that the demonstration tracings the company publishes are most plausibly movement and technical artifact rather than a physiological signal at all, and noted that the claim that the pulse reflects an energy wave rather than blood flow is straightforwardly false. He characterized the surrounding heart-intelligence framework as science-flavored storytelling built on a real but irrelevant factoid about the heart's electrical activity, and cited a review finding insufficient evidence for the premises that poor mental health tracks deviant HRV and that optimising HRV specifically reduces symptoms.

A large share of HeartMath research is authored by HeartMath Institute staff and published alongside the organization's promotional material, while the institute simultaneously sells the emWave and Inner Balance devices, certification programs, and training: an arrangement readers should weigh when assessing the in-house literature. Separately, and on independent evidence: meta-analytic work on the generic technique finds real but modest effects, g = 0.38 for depressive symptoms across 14 RCTs (Pizzoli et al., 2021), well short of the transformation implied by the marketing. The line between 'generic HRV biofeedback' and 'HeartMath' is also blurrier than either side suggests, since a number of trials pooled in those meta-analyses used HeartMath hardware and protocols.

The Global Coherence Initiative, the claim that collective human emotional states interact with the earth's magnetic field and that synchronized heart coherence can produce planetary effects, extends the model well beyond anything the physiological data supports, and is the element most often cited by critics as disqualifying. It is separable from the clinical biofeedback protocol but is promoted by the same organization.

Former patients of Castlewood Treatment Center filed lawsuits alleging they were pressured into recovering memories of abuse that had not occurred. Richard Schwartz had spent ~18 months training staff in IFS at Castlewood. IFS methods were reportedly central to the treatment approach patients alleged caused harm.

New York Magazine published an investigative report characterizing IFS as potentially problematic, alleging ‘parts work’ can be destabilizing for clients with complex trauma if protective mechanisms are bypassed too quickly.

Concerns include cost-prohibitive training with the founder; IFS-credentialed therapists privately fearing ostracism; Schwartz’s characterization of IFS as applicable to world peace and as a substitute for religion; general ‘cult-like enthusiasm.’ Evidence base described as emerging rather than robust.

Ketamine’s off-label psychiatric use operates in a regulatory gray area: no FDA approval for KAP specifically (only Spravato/esketamine for treatment-resistant depression via REMS), wide variation in dosing protocols, minimal standardization of the psychotherapy component, and concerns about clinics prioritizing volume over integration. The at-home ketamine telehealth model (Mindbloom, Joyous, etc.) has drawn particular scrutiny for minimal clinical oversight.

Matthew Perry’s death in October 2023 from acute ketamine effects brought mainstream attention to ketamine overprescription. Subsequent reporting revealed a loosely regulated ecosystem of telehealth ketamine prescribers with minimal psychiatric evaluation. Multiple providers have faced scrutiny for prescribing without adequate screening.

Physicists Alan Sokal and Jean Bricmont devoted a chapter of Fashionable Nonsense (1998) to Lacan’s use of mathematical and topological concepts, concluding his definitions were not merely wrong but ‘gibberish.’ Richard Dawkins wrote in Nature that ‘a philosopher who is caught equating the erectile organ to the square root of minus one has blown his credentials.’ The critique extended beyond Lacan to his influence on an intellectual culture that Sokal and Bricmont argued treated scientific concepts as rhetorical ornamentation.

Lacanian psychoanalysis deliberately positions itself outside empirical evaluation frameworks. Variable-length sessions (the ‘short session’) have been controversial since Lacan’s expulsion from the International Psychoanalytical Association in 1963, partly over this practice. The approach’s institutional history includes Lacan’s dissolution of his own school (École Freudienne de Paris) in 1980 and subsequent factional splits that continue to characterize the Lacanian movement.

The FDA declined to approve MDMA-assisted therapy for PTSD, citing trial design concerns, potential for bias, and safety risks. An advisory committee voted 9-2 against approval. Concerns included misconduct allegations during trials and blinding integrity questions.

Former trial participant Meaghan Buisson alleged inappropriate touch by therapists Richard Yensen and Donna Dryer during MDMA sessions. Allegations featured in the podcast Cover Story: Power Trip. Yensen’s license was subsequently surrendered.

NLP co-founder Richard Bandler was tried for the 1986 murder of Corine Christensen, who was found shot to death in her home. Bandler, who had a known history of cocaine use and volatile behavior, was acquitted after his defense argued another man present at the scene had committed the killing. The trial exposed a lifestyle of drug use and erratic conduct that contradicted NLP’s claims about personal mastery and excellence.

Multiple systematic reviews have concluded that NLP’s core theoretical claims lack empirical support. Witkowski (2010) reviewed 315 articles and found that only 18.2% supported NLP claims, concluding it represents pseudoscience. The preferred representational system theory (that people have dominant visual, auditory, or kinesthetic processing modes detectable through eye movements and language) has been repeatedly disconfirmed in controlled studies. Sturt et al. (2012) found insufficient evidence for NLP as a therapeutic intervention in a Cochrane-style review.

NLP has no unified regulatory body, resulting in competing certification organizations with variable standards. Training can range from weekend workshops to multi-month programs, with no quality control mechanism. This has created a proliferation of self-certified ‘NLP practitioners’ and ‘master practitioners’ with minimal training, many operating outside any clinical or ethical oversight framework.

Open Dialogue’s remarkable Finnish outcome data (83% return to work, 77% with no residual psychotic symptoms at 5 years) comes exclusively from naturalistic, non-randomized studies in Western Lapland. Critics argue these results may reflect selection bias, Finland’s social safety net, and secular trends in psychosis outcomes rather than the intervention itself. The approach’s emphasis on delaying or avoiding antipsychotic medication has drawn concern from mainstream psychiatry.

Jeffrey Masson’s Against Therapy (1988) included Person-Centered Therapy in a broad critique arguing that the therapeutic relationship is inherently an exercise of power, and that Rogers’ claim of unconditional positive regard masks an unavoidable power differential. Masson argued that the ‘necessary and sufficient conditions’ framework was naïve about the structural dynamics of any helping relationship.

Neuroscientist Paul Grossman published a peer-reviewed review concluding there is ‘broad consensus among experts that each basic physiological assumption of the polyvagal theory is untenable.’ Key issues: the evolutionary narrative is contradicted by social behavior in reptiles; myelinated vagus fibers exist in lungfish (contradicting mammalian uniqueness claim); Porges stated PVT ‘was not proposed to be either proven or falsified’ (inconsistent with scientific method); weak RSA-psychopathology links.

Arthur Janov made extraordinary therapeutic claims, asserting Primal Therapy could cure conditions ranging from depression and anxiety to asthma, ulcers, drug addiction, alcoholism, and homosexuality (which Janov characterized as a disorder). The approach was popularized through celebrity endorsements, most notably John Lennon, who underwent therapy with Janov in 1970 and whose album Plastic Ono Band reflected the experience. Lennon later distanced himself, saying the therapy hadn’t worked. The Primal Center in Venice, CA operated as a closed institutional environment with features critics characterized as cult-like, including isolation requirements for new patients and discouragement of outside therapy. The center closed in 2017 after Janov’s death.

No randomized controlled trial has ever been conducted on Primal Therapy. The approach is not recognized by any major psychological or psychiatric organization. Its theoretical foundation (that neurosis is caused by specific stored childhood pain that can be ‘resolved’ through cathartic discharge) contradicts modern understanding of trauma processing, which emphasizes titrated exposure and integration rather than abreaction.

Psilocybin-assisted therapy has not received FDA approval. While it holds Breakthrough Therapy designation and multiple Phase 2 trials show promising results for treatment-resistant depression, the therapy component remains unstandardized: there is no consensus on how many sessions, what kind of preparation, what the therapist does during the experience, or how integration should proceed. The FDA's 2024 rejection of MDMA-assisted therapy on methodological grounds raised concerns about whether psychedelic-assisted therapies can meet regulatory standards given the challenges of blinding and expectancy effects.

The rapid commercialization of psychedelic therapy has outpaced safety infrastructure. Reports of sexual abuse by therapists during psychedelic sessions have emerged from both clinical trials and underground settings: the altered state creates extreme vulnerability and power asymmetry. Training standards for psychedelic therapists are not established. The field has attracted significant venture capital investment, creating financial incentives to minimize safety concerns and accelerate access. Oregon's regulated psilocybin program launched without requiring participants to have a clinical diagnosis.

Razvi voluntarily forfeited his therapy license in Colorado following what he describes as an unsuccessful ‘harm reduction effort’ involving underground psychedelic work. License forfeiture carries the same effect as state revocation.

PSI denied an Israeli applicant admission, citing ‘apartheid, ethnic cleansing and credible accusations of genocide.’ The email was sent under a staff member’s name, but Razvi later admitted authorship. Faculty published a joint letter distancing themselves.

Structural concerns: proprietary apprenticeship with no external accreditor; trainees must undergo medicine sessions with PSI trainers (dual-relationship questions); cannabis as primary medicine lacks regulatory framework; no controlled outcome research beyond a white paper.

In 2005, the board of the Albert Ellis Institute, the organization Ellis founded and led for over four decades, stripped the 91-year-old Ellis of control, cancelled his credit cards, removed him from his role conducting therapy sessions, and changed the locks on his apartment within the Institute building. The board alleged financial mismanagement. Ellis, then seriously ill, maintained the board was conducting a hostile takeover of the institution he built. He sued and a New York court reinstated him, finding the board had acted improperly. Ellis died in 2007 at age 93, the dispute unresolved.

Ellis was known for an abrasive, confrontational therapeutic style that included profanity, insults, and deliberate provocation of clients. He called this 'elegant REBT' and argued it was the most efficient path to disputing irrational beliefs. While some clients found this liberating, others reported feeling shamed and dismissed. Ellis also made public statements dismissing entire therapeutic traditions (psychoanalysis, person-centered therapy) with a combativeness that many colleagues found unprofessional. His personal style became inseparable from REBT's public image.

Despite wide adoption, SE has a limited evidence base. A 2017 systematic review found only 3 controlled studies with small samples. SE’s theoretical framework (trauma stored as incomplete motor responses) lacks robust neurobiological evidence. Claims about animal ‘shaking off’ trauma have been characterized as oversimplified analogies.

Multi-level certification model (Beginning, Intermediate, Advanced + practitioner certification) requiring significant time and financial investment. Characterized by critics as a ‘modality empire’ business model.

Transpersonal psychology's core subject matter (peak experiences, mystical states, expanded consciousness, spiritual development) has been criticized as falling outside the boundaries of empirical science. The field has struggled to gain institutional acceptance within academic psychology. Critics argue it conflates psychology with religion, lacks falsifiable hypotheses, and relies on subjective reports of states that may be neurological artifacts rather than encounters with transcendent reality. The Journal of Transpersonal Psychology has limited impact factor.

Transpersonal therapy's emphasis on spiritual experiences creates risk of 'spiritual bypassing': using spiritual frameworks to avoid engaging with psychological pain, relational conflict, or structural oppression. When a therapist frames a client's suffering as a 'spiritual emergency' or 'dark night of the soul,' legitimate psychiatric conditions may go undiagnosed and untreated. The boundary between transpersonal therapy and pastoral counseling or spiritual direction is often unclear, raising questions about scope of practice.

A 2012 PRISMA systematic review found 32 of the 33 eligible Triple P trials were authored by Triple P-affiliated personnel, with only one paper disclosing a conflict of interest despite program authors receiving royalties from sales. Two independent evaluations excluded from the pooled analysis on eligibility grounds (both from the same Zurich research group, unaffiliated with the developers) found no effect on child behavior, against the developer-dominated literature's pooled effect size of 0.61. The reviewers described this pattern, positive developer-led results failing to replicate independently, as a recognized phenomenon in prevention research, and found no convincing evidence that Triple P works across the whole population or produces durable long-term benefit.

A 2015 cross-program audit of conflict-of-interest disclosure in major parenting interventions found Triple P had the lowest disclosure rate of the four programs studied (11%, against 57-73% for the others) and that contacting journal editors produced a published correction for 80% of the flagged Triple P articles. The University of Queensland licenses Triple P for worldwide commercial distribution through Triple P International; royalties pass through the university's commercialization arm, UniQuest, to the university, its Parenting and Family Support Centre, and the program's authors, including founder Matt Sanders as primary recipient, who also receives separate consulting fees from Triple P International.